Toggle Offcanvas
...
 
Pegfilgrastim Tenders

Pegfilgrastim Tenders

View Pegfilgrastim tenders, RFPs and contracts. Bid on readily available Pegfilgrastim tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Pegfilgrastim tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Pegfilgrastim.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Pegfilgrastim market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Pegfilgrastim tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

68 Live Notices for Pegfilgrastim Tenders

Showing 1 to 20

Oncological Drugs.
country Poland
posting date05 Feb 2025
deadline24 Feb 2025
Lp Containing Pegfilgrastim 2025
country Czech Republic
posting date03 Feb 2025
deadline07 Mar 2025
Delivery Of Oncological Drugs.
country Poland
posting date03 Feb 2025
deadline17 Feb 2025
Delivery Of Oncological Drugs.
country Poland
posting date24 Jan 2025
deadline10 Feb 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim, (Obo) Atc L03Aa13 For The Period 01.03.2025 - 28.02.2026 (Plus Extension Option 1X12 Months)
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim, (Obo) Atc L03Aa13 For The Period 01.03.2025 - 28.02.2026 (Plus Extension Option 1X12 Months)
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Lipegfilgrastim 6Mg06Ml Sol Inject Jrp 1000020625
country Chile
posting date15 Jan 2025
deadline13 Feb 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pegfilgrastim (L03Aa13) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Dec 2024
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Pegfilgrastim (Atc Code L03Aa13).
country Germany
posting date09 Dec 2024
deadline27 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Pegfilgrastim (Atc Code L03Aa13).
country Germany
posting date09 Dec 2024
deadline27 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026
Medicines Containing The Active Ingredient Pegfilgrastim (Atc: L03Aa13)
country Germany
posting date09 Dec 2024
deadline30 Nov 2026

Share Share this page